A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter

NCT01978860 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Total Occlusion of Coronary Artery

Interventions

DEVICE: NovaCross, CTO

Sponsor

Chanan Schneider

Collaborators

[object Object]